What is the recommended treatment for a patient with olecranon bursitis, possibly with a history of rheumatoid arthritis or gout?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Olecranon Bursitis

Initial Approach Based on Etiology

The treatment of olecranon bursitis depends critically on distinguishing between septic, inflammatory (gout/rheumatoid arthritis), and traumatic/microtraumatic causes, with conservative management preferred for most cases and corticosteroid injection reserved specifically for inflammatory etiologies. 1, 2

Septic vs. Aseptic Differentiation

  • If infection is suspected (fever, severe erythema, warmth, systemic symptoms), perform bursal aspiration immediately with fluid analysis including Gram stain, culture, cell count with differential, glucose, and crystal analysis 2
  • Septic bursitis requires antibiotics effective against Staphylococcus aureus as initial treatment, with outpatient oral therapy acceptable for non-acutely ill patients and intravenous antibiotics for those who are acutely ill 2
  • Ultrasonography can help distinguish bursitis from cellulitis when the diagnosis is unclear 2

Treatment Algorithm by Etiology

Gout-Related Olecranon Bursitis

For gout-related bursitis, initiate anti-inflammatory therapy within 24 hours of symptom onset using colchicine, NSAIDs, or glucocorticoids as first-line options. 1, 3

  • Low-dose colchicine (1.2 mg immediately followed by 0.6 mg one hour later) is strongly preferred over high-dose regimens due to similar efficacy with fewer adverse effects 1, 4
  • NSAIDs are highly effective when initiated promptly; naproxen is FDA-approved for acute gout and bursitis 5
  • Glucocorticoids (oral prednisone 0.5 mg/kg/day for 5-10 days, or intrabursal injection) are appropriate alternatives, particularly when NSAIDs are contraindicated 1, 4
  • Intrabursal corticosteroid injection is appropriate for gout-related olecranon bursitis, as this represents inflammatory rather than microtraumatic bursitis 1, 2
  • Address the underlying condition by initiating or optimizing urate-lowering therapy, with anti-inflammatory prophylaxis continued for at least 3-6 months 1

Rheumatoid Arthritis-Related Bursitis

  • Treat the underlying inflammatory condition with disease-modifying antirheumatic drugs (DMARDs) as per standard rheumatoid arthritis management 3
  • Intrabursal corticosteroid injections are often used for chronic inflammatory bursitis related to rheumatoid arthritis 2
  • Glucocorticoid injections may be helpful at the elbow for inflammatory bursitis, with ultrasound guidance if needed 3

Traumatic/Microtraumatic (Aseptic) Bursitis

Conservative management is the first-line treatment for traumatic olecranon bursitis, with aspiration potentially shortening symptom duration but corticosteroid injection NOT recommended due to significant complication risks. 6, 2, 7

  • Initial conservative therapy: ice, elevation, rest, and analgesics (NSAIDs) 6, 2
  • Aspiration alone may shorten symptom duration for acute traumatic/hemorrhagic bursitis without increasing infection risk 2, 7
  • Avoid corticosteroid injection for microtraumatic bursitis—it is associated with significantly increased complications including infection (3/25 patients), skin atrophy (5/25 patients), and chronic local pain (7/25 patients) without improving outcomes 7, 8, 9
  • Address underlying repetitive trauma or occupational factors (e.g., prolonged leaning on elbows) 2

Critical Pitfalls to Avoid

  • Do not inject corticosteroids into microtraumatic/traumatic bursitis: A 1984 study showed that while corticosteroid injection provided rapid recovery (within one week), it resulted in infection in 12%, skin atrophy in 20%, and chronic pain in 28% of patients, whereas aspiration alone had no complications 8
  • Do not aspirate microtraumatic bursitis routinely: Repeated aspiration increases the risk of iatrogenic septic bursitis without clear benefit 2
  • Surgical management should be avoided: Surgery is associated with significantly lower clinical resolution rates and higher complication rates (persistent drainage, infection) compared to nonsurgical management for both septic and aseptic bursitis 7
  • Reserve surgery only for: septic bursitis unresponsive to antibiotics or recurrent cases 2

When Conservative Management Fails

  • For refractory aseptic bursitis unresponsive to 6-8 weeks of conservative treatment, corticosteroid injection may be considered, but only after excluding infection and with full patient counseling about complication risks 9
  • Arthroscopic bursectomy is increasingly considered as a minimally invasive option for truly refractory cases, avoiding wound complications of open excision 6

References

Guideline

Management of Olecranon Bursitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Common Superficial Bursitis.

American family physician, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differentiating and Managing Bunion vs Gout Flare

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and management of olecranon bursitis.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 2012

Research

Treatment of olecranon bursitis: a systematic review.

Archives of orthopaedic and trauma surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.